Compositions and methods for recognition of RNA using triple helix forming peptide nucleic acids

US10385100B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10385100-B2
Application numberUS-201615221021-A
CountryUS
Kind codeB2
Filing dateJul 27, 2016
Priority dateOct 29, 2012
Publication dateAug 20, 2019
Grant dateAug 20, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Peptide nucleic acids containing thymidine and 2-aminopyridine (M) nucleobases formed stable and sequence selective triple helices with double stranded RNA at physiologically relevant conditions. The M-modified PNA displayed unique RNA selectivity by having two orders of magnitude higher affinity for the double stranded RNAs than for the same DNA sequences. Preliminary results suggested that nucleobase-modified PNA could bind and recognize double helical precursors of microRNAs.

First claim

Opening claim text (preview).

What is claimed is: 1. A peptide nucleic acid, comprising: a polypeptide comprising a series of N-(2-aminoethyl)-glycines, each N-(2-aminoethyl)-glycine being ligated to a respective Base, and wherein at least one of the respective Bases is 2-aminopyridine: such that at least one N-(2-aminoethyl)-glycine ligated to a Base is 2-aminopyridine-ligated to a N-(2-aminoethyl)-glycine: further comprising at least one basic amino acid ligated to the polypeptide. 2. The peptide nucleic acid according to claim 1 , wherein the at least one basic amino acid comprises at least one terminal lysine ligated to the polypeptide. 3. The peptide nucleic acid according to claim 1 , wherein at least four bases are 2-aminopyridine. 4. The peptide nucleic acid according to claim 1 , wherein at least two sequential bases are 2-aminopyridine. 5. The peptide nucleic acid according to claim 1 , wherein the polypeptide comprises at least six sequential base-ligated N-(2-aminoethyl)-glycines. 6. The peptide nucleic acid according to claim 1 , in combination with a double stranded RNA, wherein the peptide nucleic acid forms a base sequence selective triple helix with the double stranded RNA substantially without strand invasion. 7. The peptide nucleic acid according to claim 1 , wherein the peptide nucleic acid is configured to form a triple helix with a double stranded RNA having a corresponding base sequence with the peptide nucleic acid, substantially without strand invasion, which is stable at pH 7.4. 8. The peptide nucleic acid according to claim 7 , wherein the peptide nucleic acid is configured to form the triple helix with the double stranded RNA, in a base sequence-selective manner at pH 7.4 at a temperature of 37° C. in an aqueous buffer comprising 2 mM MgCl 2 , 90-mM KCl, 10 mM NaCl, and 50 mM potassium phosphate. 9. A peptide nucleic acid (PNA), comprising: a polypeptide comprising a series of at least six N-(2-aminoethyl)-glycines, each N-(2-aminoethyl)-glycine being ligated to a respective Base, wherein at least one respective Base comprises 2-aminopyridine, further comprising at least one basic amino acid ligated to the polypeptide. 10. The peptide nucleic acid according to claim 9 , wherein the at least one basic amino acid ligated to the polypeptide comprises lysine. 11. The peptide nucleic acid according to claim 9 , wherein at least two bases are 2-aminopyridine Bases. 12. The peptide nucleic acid according to claim 9 , wherein the polypeptide comprises at least six sequential base-ligated N-(2-aminoethyl)-glycines. 13. The peptide nucleic acid according to claim 9 , in combination with a double stranded RNA, wherein the peptide nucleic acid forms a base sequence-selective triple helix with the double stranded RNA. 14. A peptide nucleic acid (PNA), comprising a polypeptide comprising a series of N-(2-aminoethyl)-glycines, each N-(2-aminoethyl)-glycine being ligated to a respective base, wherein at least one respective base comprises 2-aminopyridine, configured to form a triple helix in sequence-selective manner with a double stranded ribonucleic acid which is stable at 37° C. in a pH 7.4 aqueous buffer comprising 2 mM MgCl 2 , 90-mM KCl, 10 mM NaCl, and 50 mM potassium phosphate. 15. The peptide nucleic acid according to claim 14 , configured to form, in combination with a double stranded RNA, a base sequence selective triple helix with the double stranded RNA substantially without strand invasion. 16. The peptide nucleic acid according to claim 14 , wherein at least one N-(2-aminoethyl)-glycine ligated to the respective base comprises: 17. The peptide nucleic acid according to claim 14 , further comprising at least one amino acid ligated to the series of N-(2-aminoethyl)-glycines. 18. The peptide nucleic acid according to claim 17 , wherein the at least one amino acid comprises lysine. 19. The peptide nucleic acid according to claim 9 , wherein at least one N-(2-aminoethyl)-glycine ligated to the respective Base comprises:

Assignees

Inventors

Classifications

  • C07K14/003Primary

    Peptide-nucleic acids (PNAs) · CPC title

  • Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof · CPC title

  • C12Q1/6839Primary

    Triple helix formation or other higher order conformations in hybridisation assays · CPC title

  • having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68) · CPC title

  • incorporating a peptide nucleic acid · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10385100B2 cover?
Peptide nucleic acids containing thymidine and 2-aminopyridine (M) nucleobases formed stable and sequence selective triple helices with double stranded RNA at physiologically relevant conditions. The M-modified PNA displayed unique RNA selectivity by having two orders of magnitude higher affinity for the double stranded RNAs than for the same DNA sequences. Preliminary results suggested that nu…
Who is the assignee on this patent?
Univ New York State Res Found, The Research Foundation For The State Univ O
What technology area does this patent fall under?
Primary CPC classification C07K14/003. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).